✦ LIBER ✦

A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

✍ Scribed by Dr Sam Schulman, Ammar Majeed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fondaparinux and prevention of venous th

✍ Alexander GG Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 60 KB

Program for the prevention of venous thr

✍ Reis, Steven E.; Hirsch, Denise R.; Wilson, Michael G.; Donovan, Barbara C.; Gol 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Flexibility in Administration of Fondapa

✍ Clifford W. Colwell Jr; Lewis M. Kwong; Alexander G.G. Turpie; Bruce L. Davidson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 216 KB

PCV114 DABIGATRAN ETEXILATE IS COST-SAVI

✍ C Boersma; BS Kappelhoff; MJ Postma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Ximelagatran approved in France for prev

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Venous Thromboembolism: A Review of Risk

✍ David Bergqvist 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 240 KB